BG104706A - Производни на 1,3,4-оксадиазолон - Google Patents

Производни на 1,3,4-оксадиазолон

Info

Publication number
BG104706A
BG104706A BG104706A BG10470600A BG104706A BG 104706 A BG104706 A BG 104706A BG 104706 A BG104706 A BG 104706A BG 10470600 A BG10470600 A BG 10470600A BG 104706 A BG104706 A BG 104706A
Authority
BG
Bulgaria
Prior art keywords
oxadiazolone
derivatives
solvate
disorders
responsive
Prior art date
Application number
BG104706A
Other languages
English (en)
Inventor
Piyasena Hewawasam
Min Ding
John STARRETT
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of BG104706A publication Critical patent/BG104706A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Съединенията се прилагат за лечение на заболявания в резултат от нарушено функциониране, поляризацията и проводимостта на клетъчните мембрани, лесно податливи на отварянето на високопроводящите, калцийактивируеми калиеви канали. Производните на 1,3,4-оксадиазолона или тяхна нетоксична фармацевтичноприемлива сол или солват имат обща формула@@в която А, В, D и R имат значенията, посочени в описанието.
BG104706A 1998-01-29 2000-08-22 Производни на 1,3,4-оксадиазолон BG104706A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29
PCT/US1999/000910 WO1999038510A1 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone

Publications (1)

Publication Number Publication Date
BG104706A true BG104706A (bg) 2001-04-30

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104706A BG104706A (bg) 1998-01-29 2000-08-22 Производни на 1,3,4-оксадиазолон

Country Status (27)

Country Link
US (1) US6034113A (bg)
EP (1) EP1051173A4 (bg)
JP (1) JP2002527352A (bg)
KR (1) KR20010077838A (bg)
CN (1) CN1150175C (bg)
AR (1) AR010712A1 (bg)
AU (1) AU735704B2 (bg)
BG (1) BG104706A (bg)
BR (1) BR9913010A (bg)
CA (1) CA2318830A1 (bg)
CO (1) CO5090837A1 (bg)
EE (1) EE04089B1 (bg)
GE (1) GEP20032914B (bg)
HU (1) HUP0102025A3 (bg)
ID (1) ID26909A (bg)
IL (1) IL137518A0 (bg)
LT (1) LT4838B (bg)
LV (1) LV12559B (bg)
NO (1) NO317102B1 (bg)
NZ (1) NZ505409A (bg)
PL (1) PL342060A1 (bg)
RU (1) RU2202548C2 (bg)
SK (1) SK10852000A3 (bg)
TR (1) TR200002019T2 (bg)
TW (1) TW550075B (bg)
UA (1) UA58579C2 (bg)
WO (1) WO1999038510A1 (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056731A4 (en) * 1998-01-29 2002-07-31 Bristol Myers Squibb Co AMINOACID DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE
CN1133636C (zh) * 1999-01-29 2004-01-07 布里斯托尔-米尔斯·斯奎布公司 二芳基1,3,4－噁二唑酮的氨基甲酸酯衍生物
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
CA2438868A1 (en) 2001-02-20 2002-09-19 Valentin K. Gribkoff Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases
WO2002083111A2 (en) * 2001-04-16 2002-10-24 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
CN116898848A (zh) 2012-01-18 2023-10-20 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN110545809A (zh) * 2017-02-24 2019-12-06 奥维德医疗公司 治疗发作性疾病的方法
WO2020086149A1 (en) 2018-10-26 2020-04-30 University Of South Florida Drug for treating tinnitus
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (bg) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
EP1056731A4 (en) * 1998-01-29 2002-07-31 Bristol Myers Squibb Co AMINOACID DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE

Also Published As

Publication number Publication date
IL137518A0 (en) 2001-07-24
GEP20032914B (en) 2003-03-25
JP2002527352A (ja) 2002-08-27
LV12559A (en) 2000-11-20
NZ505409A (en) 2003-08-29
CO5090837A1 (es) 2001-10-30
HUP0102025A3 (en) 2002-01-28
TW550075B (en) 2003-09-01
EE04089B1 (et) 2003-08-15
AU735704B2 (en) 2001-07-12
NO20003825L (no) 2000-07-26
CN1150175C (zh) 2004-05-19
EP1051173A4 (en) 2002-07-31
LT4838B (lt) 2001-08-27
BR9913010A (pt) 2001-05-08
WO1999038510A1 (en) 1999-08-05
HUP0102025A2 (hu) 2001-11-28
AU2230899A (en) 1999-08-16
EP1051173A1 (en) 2000-11-15
CA2318830A1 (en) 1999-08-05
KR20010077838A (ko) 2001-08-20
RU2202548C2 (ru) 2003-04-20
US6034113A (en) 2000-03-07
UA58579C2 (uk) 2003-08-15
CN1289249A (zh) 2001-03-28
LT2000068A (en) 2001-03-26
NO20003825D0 (no) 2000-07-26
SK10852000A3 (sk) 2002-02-05
LV12559B (en) 2001-04-20
NO317102B1 (no) 2004-08-09
ID26909A (id) 2001-02-15
PL342060A1 (en) 2001-05-21
EE200000447A (et) 2001-12-17
TR200002019T2 (tr) 2000-11-21
AR010712A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
MY115935A (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
BG104706A (bg) Производни на 1,3,4-оксадиазолон
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
CA2354023A1 (en) Phenylglycine derivatives
CA2348735A1 (en) Heterocyclic potassium channel inhibitors
BG105270A (bg) Тетрахидропиридоетери
HUP0100779A3 (en) Novel derivatives of 3,3-diphenylpropylamines
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
BG103590A (bg) Пестицидни 1-арилпиразоли
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
AP2002002637A0 (en) Novel piperazine
CA2054590A1 (en) Novel cyclosporins
AU5162796A (en) Novel peptide derivatives
AU6563596A (en) Treatment of tinnitis using neuroprotective agents
BG103310A (bg) Бензонафтиридини като бронхиални лечебни средства
CA2474511A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
PT1056754E (pt) Derivados fosfatados de 1,3,4-oxadiazolona de diarilo
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
WO1996032403A3 (de) Neue cytosin- und cytidinderivate
NZ515025A (en) Solvates of pymetrozine
USD427384S (en) Hockey glove
DE69837999D1 (en) Herbizide furanyl- und thienyloxyazine
EP1575589A4 (en) ATROPISOMERS OF 4-ARYLQUINOLIN-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3
DE69116057D1 (de) Mikrobische Herstellung des 13-beta-13-deoxy-22,23,-dihydroavermectin-Bla/B1b-Aglycons